WEE1 KINASE INHIBITION: A PROMISING STRATEGY FOR SENSITIZING DIFFUSE INTRINSIC PONTINE GLIOMAS TO IRRADIATION

被引：0
|
作者：
Caretti, Viola [1 ]
Hiddingh, Lotte [1 ]
Lagerweij, Tonny [1 ]
Koken, Phil W. [1 ]
Hulleman, Esther [1 ]
Vandertop, W. Peter [1 ]
Noske, David P. [1 ]
Kaspers, Gertjan G. [1 ]
Wurdinger, Thomas [1 ]
机构：
[1] Vrije Univ Amsterdam, Med Ctr, Amsterdam, Netherlands
来源：
NEURO-ONCOLOGY | 2011年 / 13卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [41] TARGETING A NOVEL METABOLIC DEFECT IN PPM1DMUTANT DIFFUSE INTRINSIC PONTINE GLIOMAS
    Fons, Nathan
    Sundaram, Ranjini
    Breuer, Greg
    Brenner, Charles
    Bindra, Ranjit
    NEURO-ONCOLOGY, 2018, 20 : 208 - 208
  • [42] COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
    Khan, Aaminah
    Gamble, Laura
    Pandher, Ruby
    Burns, Mark R.
    Mussai, Francis
    Norris, Murray
    Haber, Michelle
    Tsoli, Maria
    Ziegler, David S.
    NEURO-ONCOLOGY, 2020, 22 : 290 - 290
  • [43] POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
    Khan, Aaminah
    Gamble, Laura
    Upton, Dannielle
    Yu, Denise
    Ehteda, Anahid
    Pandher, Ruby
    Mayoh, Chelsea
    Burns, Mark
    Norris, Murray
    Haber, Michelle
    Tsoli, Maria
    Ziegler, David
    NEURO-ONCOLOGY, 2020, 22 : 289 - 290
  • [44] POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
    Khan, Aaminah
    Gamble, Laura
    Upton, Dannielle
    Yu, Denise
    Pandher, Ruby
    Mayoh, Chelsea
    Burns, Mark R.
    Norris, Murray D.
    Haber, Michelle
    Tsoli, Maria
    Ziegler, David S.
    NEURO-ONCOLOGY, 2021, 23 : 40 - 41
  • [45] Targeted inhibition of homologous recombination and nonhomologous end joining in diffuse intrinsic pontine gliomas to prevent tumor recurrence
    Barravecchia, Ivana
    Sharma, Monika
    Teis, Robert
    Cruz, Jeanette
    Mumby, Rachel
    Ziemke, Elizabeth
    Espinoza, Carlos
    Magnuson, Brian
    Ljungman, Mats
    Koschmann, Carl
    Whitehead, Christopher
    Sebolt-Leopold, Judith
    Galban, Stefanie
    MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [46] Uncovering molecular subgroups and a novel cancer driver, ACVR1 in diffuse intrinsic pontine gliomas
    Buczkowicz, Pawel
    Hoeman, Christine
    Rakopoulos, Patricia
    Pajovic, Sanja
    Morrison, Andrew
    Bouffet, Eric
    Bartels, Ute
    Becher, Oren
    Hawkins, Cynthia
    CANCER RESEARCH, 2014, 74 (20)
  • [47] Combined Inhibition of ATR and WEE1 as a Novel Therapeutic Strategy in Triple-Negative Breast Cancer
    Jin, Juan
    Fang, Hehui
    Yang, Fang
    Ji, Wenfei
    Guan, Nan
    Sun, Zijia
    Shi, Yaqin
    Zhou, Guohua
    Guan, Xiaoxiang
    NEOPLASIA, 2018, 20 (05): : 478 - 488
  • [48] Diffuse intrinsic pontine gliomas: the future of combination therapy with mTORC1/2 inhibitors and radiation
    Garcia, Idoia
    Aldareguia, Juncal
    Matheu, Ander
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S1098 - S1100
  • [49] TRX-E-009-1 IS A NOVEL AND A POTENT THERAPEUTIC AGENT FOR DIFFUSE INTRINSIC PONTINE GLIOMAS
    Ehteda, Anahid
    Kankean, Anne
    Chitranjan, Arjanna
    Tsoli, Maria
    Liu, Jie
    Shen, Han
    Franshaw, Laura
    Joshi, Swapna
    Chang, Cecilia
    Ager, Eleanor
    Ziegler, David S.
    NEURO-ONCOLOGY, 2017, 19 : 6 - 6
  • [50] Sensitization of Pancreatic Cancers to Gemcitabine Chemoradiation by WEE1 Kinase Inhibition Depends on Homologous Recombination Repair
    Kausar, Tasneem
    Schreiber, Jason S.
    Karnak, David
    Parsels, Leslie A.
    Parsels, Joshua D.
    Davis, Mary A.
    Zhao, Lili
    Maybaum, Jonathan
    Lawrence, Theodore S.
    Morgan, Meredith A.
    NEOPLASIA, 2015, 17 (10): : 757 - 766
12345